List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 478 studies with search of: Methyltestosterone
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice
Conditions: Male;   Hypogonadism
Intervention: Drug: Testosterone Undecanoate (Nebido, BAY86-5037)
2 Recruiting Effect of Androgel on Type 2 Diabetic Males With Hypogonadism
Condition: Diabetes Mellitus Type 2
Interventions: Drug: androgel;   Drug: androgel 10g;   Drug: placebo
3 Recruiting Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer
Conditions: Prostate Cancer;   Castration-resistant, Metastatic
Intervention: Other: testosterone (AndroGel®) with the 5α-reductase inhibitor dutasteride
4 Recruiting Testosterone for Penile Rehab After Radical Prostatectomy
Conditions: Low Testosterone Levels;   Erectile Dysfunction
Interventions: Drug: Testim® + Viagra®;   Drug: Placebo Testim® + Viagra®
5 Recruiting Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men
Condition: Sarcopenia
Interventions: Drug: Testosterone injection;   Drug: Testosterone gel
6 Terminated A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®
Condition: Hypoactive Sexual Desire Disorder
Interventions: Drug: Testosterone Spray 5% and 1%;   Drug: Intrinsa® Patch and Testosterone Spray 5%;   Drug: Intrinsa® Patch and Testosterone Spray 1%
7 Completed Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone
Conditions: Erectile Dysfunction;   Hypogonadism
Interventions: Drug: Testosterone gel;   Drug: testosterone;   Other: placebo gel
8 Completed A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Androderm® 2.5mg;   Drug: Androderm® 5.0mg;   Drug: Androderm® 7.5mg
9 Completed Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
Condition: Hypogonadism
Interventions: Drug: Nanomilled testosterone;   Drug: commercially available dutasteride;   Drug: Nanomilled dutasteride
10 Not yet recruiting Influence of Administration Route of Testosterone on Male Fertility
Condition: Hypogonadism
Interventions: Drug: MPP10, testosterone;   Drug: Testosterone
11 Completed Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men
Condition: Hypogonadism
Interventions: Drug: Testosterone undecanoate (TU);   Drug: TU + testosterone enanthate (TE)
12 Recruiting Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients
Condition: Advanced Cancer
Interventions: Drug: Testosterone;   Drug: Placebo
13 Not yet recruiting Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
Conditions: Type 2 Diabetes;   Hypogonadism
Intervention: Drug: Testosterone
14 Withdrawn Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes
Conditions: Hypogonadism;   Diabetes
Interventions: Drug: Testosterone gel;   Drug: placebo
15 Recruiting Effect of Testosterone in Men With Erectile Dysfunction
Conditions: Erectile Dysfunction;   Testosterone Deficiency;   Diabetes
Interventions: Drug: Sildenafil citrate (open label);   Drug: Testosterone gel 1% (active or placebo);   Drug: Topical testosterone gel 1%
16 Completed A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone
Condition: Hypogonadism
Intervention: Drug: Testosterone
17 Completed Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males
Condition: Hypogonadism
Intervention: Drug: Testosterone Gel 1.62%
18 Completed Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism
Condition: Hypogonadism
Intervention: Drug: Testosterone (Testogel), GnRH analog (Leuprorelide) and Placebo
19 Completed 28-Day Study of Testosterone Co-Administered With Dutasteride in Hypogonadal Men
Condition: Hypogonadism
Interventions: Drug: Nanomilled testosterone;   Drug: Nanomilled dutasteride;   Drug: commercially available dutasteride
20 Active, not recruiting HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone
Condition: Healthy Males
Interventions: Drug: Acyline;   Other: placebo hCG (no active ingredient);   Drug: hCG (human chorionic gonadotropin);   Drug: Testosterone gel

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services